fda bpc-157 category 2 compounding list Peptide Reclassification 2026: What It Means for Providers This just in: The FDA
This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy Repost @peptides with @use.repost BREAKING NEWS! Today's 86 advisory vote for BPC 157 is one of the biggest peptide regulatory developments we've seen in years. While nothing changes immediately, the recommendation represents A big shift in the peptide landscape!! It's being reported that many of the peptides previously restricted under FDA compounding guidance may soon be able to be legally compounded again through
Pay in 4 interest-free payments of $6.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
